BRÈVE publiée le 22/10/2024 à 13:05, il y a 1 année 8 mois Releaf Signs Historic Medical Cannabis Deal in the UK Medical Cannabis Glass Pharms UK Market Growth Releaf Deal Sustainable Partnership
BRÈVE publiée le 22/10/2024 à 13:05, il y a 1 année 8 mois Releaf signe un accord historique sur le cannabis médical au Royaume-Uni Cannabis Médical Accord De Relance Verrerie Pharmaceutique Croissance Du Marché Britannique Partenariat Durable
COMMUNIQUÉ DE PRESSE publié le 22/10/2024 à 13:00, il y a 1 année 8 mois UKs Largest Medical Cannabis Deal Signed by Releaf UK's largest medical cannabis contract signed between Releaf and Glass Pharms, ensuring reliable supply. Releaf to become UK's largest provider with cutting-edge technology UK Market Supply Chain Medical Cannabis Releaf Glass Pharms
BRÈVE publiée le 09/10/2024 à 12:15, il y a 1 année 8 mois Releaf and SOMAÍ Forge Exclusive UK Cannabis Partnership Partnership Patient Care Medical Cannabis Releaf SOMAÍ
BRÈVE publiée le 09/10/2024 à 12:15, il y a 1 année 8 mois Releaf et SOMAÍ concluent un partenariat exclusif dans le domaine du cannabis au Royaume-Uni Partenariat Cannabis Médical Releaf Soins Aux Patients SOMAÍ
COMMUNIQUÉ DE PRESSE publié le 09/10/2024 à 12:10, il y a 1 année 8 mois Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal Releaf partners with SOMAÍ Pharmaceuticals to bring innovative cannabis solutions to UK patients, offering high-quality treatments and exclusive access to products. The collaboration aims to revolutionize patient care Partnership Releaf SOMAÍ Pharmaceuticals Cannabis Solutions UK Patients
BRÈVE publiée le 12/06/2024 à 16:50, il y a 2 années Releaf Offers Industry First UK-Grown Medical Cannabis with Glass Pharms Partnership Sustainability Partnership Medical Cannabis UK-Grown Releaf
BRÈVE publiée le 12/06/2024 à 16:50, il y a 2 années Releaf propose le premier cannabis médical cultivé au Royaume-Uni avec le partenariat Glass Pharms Partenariat Durabilité Cannabis Médical Cultivé Au Royaume-Uni Libérer
COMMUNIQUÉ DE PRESSE publié le 12/06/2024 à 16:45, il y a 2 années Releaf Offers Industry First UK-Grown Cannabis Releaf announces partnership with Glass Pharms to offer UK-grown medical cannabis, supporting domestic cultivation and patient access to sustainable medication. Groundbreaking collaboration for UK medical cannabis market Releaf Glass Pharms UK-grown Medical Cannabis Sustainable Medication Domestic Cultivation
Publié le 30/06/2026 à 15:06, il y a 1 heure 24 minutes 260630 BENETEAU Transactions sur actions propres
Publié le 30/06/2026 à 07:30, il y a 9 heures Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Publié le 30/06/2026 à 07:30, il y a 9 heures Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Publié le 30/06/2026 à 15:00, il y a 1 heure 30 minutes Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Publié le 30/06/2026 à 15:00, il y a 1 heure 30 minutes BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Publié le 30/06/2026 à 15:00, il y a 1 heure 30 minutes Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Publié le 30/06/2026 à 14:00, il y a 2 heures 30 minutes Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Publié le 30/06/2026 à 16:05, il y a 25 minutes Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
